Technical Analysis for PFE - Pfizer, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
NR7-2 | Range Contraction | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
NR7 | Range Contraction | -0.79% | |
Overbought Stochastic | Strength | -0.79% | |
Gapped Down | Weakness | -0.79% | |
Stochastic Sell Signal | Bearish | -1.46% | |
Overbought Stochastic | Strength | -1.46% | |
Shooting Star Candlestick | Bearish | -1.77% |
Alert | Time |
---|---|
Possible NR7 | about 9 hours ago |
Fell Below Previous Day's Low | about 13 hours ago |
Down 1% | about 13 hours ago |
Possible NR7 | 3 days ago |
60 Minute Opening Range Breakdown | 4 days ago |
Get a Trading Assistant
- Earnings date: 04/30/2024
Pfizer, Inc. Description
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: S&P 500 Biopharmaceutical Disease Pain Medication Clinic Neuroscience Pharmaceutical Products Inflammation Alzheimer's Disease Hypertension Dietary Supplement Ophthalmology Animal Health Pain Management Dysfunction Major Depressive Disorder Pulmonary Arterial Hypertension Depressive Disorder Primary Care Smoking Hemophilia Smoking Cessation Anti Infectives Endocrine Disorders Erectile Dysfunction Livestock Producers Prescription Product Prescription Products Genitourinary
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 40.154 |
52 Week Low | 25.3781 |
Average Volume | 44,810,386 |
200-Day Moving Average | 31.32 |
50-Day Moving Average | 27.55 |
20-Day Moving Average | 27.32 |
10-Day Moving Average | 27.57 |
Average True Range | 0.62 |
RSI (14) | 52.83 |
ADX | 13.56 |
+DI | 25.82 |
-DI | 22.26 |
Chandelier Exit (Long, 3 ATRs) | 26.84 |
Chandelier Exit (Short, 3 ATRs) | 27.46 |
Upper Bollinger Bands | 28.68 |
Lower Bollinger Band | 25.95 |
Percent B (%b) | 0.65 |
BandWidth | 9.99 |
MACD Line | 0.13 |
MACD Signal Line | -0.01 |
MACD Histogram | 0.1402 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 28.34 | ||||
Resistance 3 (R3) | 28.38 | 28.20 | 28.24 | ||
Resistance 2 (R2) | 28.20 | 28.04 | 28.18 | 28.20 | |
Resistance 1 (R1) | 27.96 | 27.94 | 27.87 | 27.93 | 28.17 |
Pivot Point | 27.79 | 27.79 | 27.74 | 27.77 | 27.79 |
Support 1 (S1) | 27.55 | 27.63 | 27.46 | 27.51 | 27.27 |
Support 2 (S2) | 27.37 | 27.53 | 27.35 | 27.24 | |
Support 3 (S3) | 27.13 | 27.37 | 27.20 | ||
Support 4 (S4) | 27.10 |